Previous close | 0.7000 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 77.00 |
Expiry date | 2024-11-08 |
Day's range | 0.7000 - 0.7000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Glaukos announces positive second Phase 3 confirmatory pivotal trial for Epioxa.
ARAY's solid product demand and revenue growth raise optimism about the stock.
Bruker announces the formation of the new Bruker Spatial Biology division.